lanreotide Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmyocardial infarction

I am/have/hadgilbert's syndrome

I am/have/hadpannet

I am/have/hadneuroendocrine tumor

I am/have/hadtransient ischemic attack

I am/have/hadpancreatic net

I am/have/hadintestinal neuroendocrine tumor

I am/have/hadpulmonary embolism

I am/have/hadcarcinoma

I am/have/hadcoronary artery bypass graft surgery

I am/have/hadcore needle biopsy

I am/have/hadprotein/creatinine ratio

I am/have/hadpancreatitis

I am/have/hadactivated partial thromboplastin time

I am/have/hadlipase

I am/have/hadelectrolyte disturbances

I am/have/hadcarcinoma in situ

I am/have/hadwhite blood cell count

I am/have/hadcancer

I am/have/hadbland embolization

added new label for I am/have/had

more

I am looking for

I am looking foredotreotide

I am looking forplatelet inhibitors

I am looking forlipase

I am looking forthrombin

I am looking forwarfarin

I am looking forsomatostatin

I am looking forcorticosteroids

I am looking foranticoagulants

I am looking forcabozantinib

I am looking forexperimental drug

I am looking forclopidogrel

I am looking forlanreotide

I am looking forvascular endothelial growth factor

I am looking forelectrolytes

I am looking forvegf

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Neurology
Recruiting

A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

A Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET): The LOLA trial

myocardial infarction

gilbert's syndrome

pannet

neuroendocrine tumor

transient ischemic attack

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.